Free Trial

FY2025 EPS Estimates for IMAX Boosted by Barrington Research

IMAX logo with Consumer Discretionary background

Key Points

  • Analysts at Barrington Research increased their earnings per share (EPS) estimate for IMAX in FY2025 from $0.86 to $0.93, with a target price set at $32.00.
  • As of now, IMAX's stock has a consensus rating of "Moderate Buy", with a price target averaging $32.80, reflecting significant confidence from analysts.
  • IMAX announced a $100 million stock repurchase plan, indicating the board's belief that the shares are currently undervalued.
  • Interested in IMAX? Here are five stocks we like better.

IMAX Corporation (NYSE:IMAX - Free Report) - Analysts at Barrington Research raised their FY2025 earnings estimates for IMAX in a research note issued to investors on Friday, September 5th. Barrington Research analyst P. Sholl now expects that the company will earn $0.93 per share for the year, up from their prior estimate of $0.86. Barrington Research currently has a "Outperform" rating and a $32.00 target price on the stock. The consensus estimate for IMAX's current full-year earnings is $0.91 per share. Barrington Research also issued estimates for IMAX's FY2026 earnings at $0.92 EPS.

A number of other brokerages have also recently commented on IMAX. B. Riley reaffirmed a "buy" rating and issued a $36.00 target price on shares of IMAX in a report on Friday, May 16th. Wall Street Zen cut shares of IMAX from a "strong-buy" rating to a "buy" rating in a report on Friday, August 22nd. Rosenblatt Securities upped their target price on shares of IMAX from $35.00 to $37.00 and gave the company a "buy" rating in a report on Friday, July 25th. The Goldman Sachs Group reissued a "sell" rating on shares of IMAX in a report on Friday, July 25th. Finally, Wells Fargo & Company increased their price target on shares of IMAX from $30.00 to $34.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $32.80.

Get Our Latest Stock Analysis on IMAX

IMAX Stock Performance

Shares of NYSE:IMAX opened at $29.75 on Monday. The company has a 50-day simple moving average of $27.03 and a 200-day simple moving average of $26.20. IMAX has a one year low of $18.76 and a one year high of $29.82. The stock has a market capitalization of $1.60 billion, a price-to-earnings ratio of 49.58, a PEG ratio of 2.02 and a beta of 0.68.

IMAX (NYSE:IMAX - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. IMAX had a net margin of 9.04% and a return on equity of 8.62%. The business had revenue of $91.68 million during the quarter, compared to analysts' expectations of $93.04 million. During the same period in the prior year, the company earned $0.18 earnings per share. The business's revenue was up 3.1% compared to the same quarter last year.

IMAX announced that its board has approved a stock repurchase plan on Thursday, June 12th that allows the company to repurchase $100.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.5% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its shares are undervalued.

Insider Transactions at IMAX

In other IMAX news, insider Kenneth Ian Weissman sold 15,072 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $25.65, for a total value of $386,596.80. Following the completion of the transaction, the insider directly owned 26,133 shares of the company's stock, valued at approximately $670,311.45. This trade represents a 36.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 24.08% of the company's stock.

Institutional Trading of IMAX

Several large investors have recently modified their holdings of IMAX. TD Waterhouse Canada Inc. grew its position in shares of IMAX by 125.0% in the second quarter. TD Waterhouse Canada Inc. now owns 900 shares of the company's stock valued at $25,000 after purchasing an additional 500 shares during the last quarter. Creative Financial Designs Inc. ADV acquired a new stake in shares of IMAX in the first quarter valued at approximately $59,000. Ridgewood Investments LLC acquired a new stake in shares of IMAX in the second quarter valued at approximately $62,000. Tower Research Capital LLC TRC grew its position in shares of IMAX by 194.6% in the second quarter. Tower Research Capital LLC TRC now owns 4,148 shares of the company's stock valued at $116,000 after purchasing an additional 2,740 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of IMAX in the first quarter valued at approximately $202,000. 93.51% of the stock is currently owned by institutional investors and hedge funds.

IMAX Company Profile

(Get Free Report)

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

Featured Articles

Earnings History and Estimates for IMAX (NYSE:IMAX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IMAX Right Now?

Before you consider IMAX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.

While IMAX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.